Relationship Between Glycemic Indices and eGFR Values Among Type 2 Diabetes Mellitus Individuals With Chronic Kidney Disease Across Various Progression Stages

For determining long-term blood sugar management and forecasting the course of kidney disease in individuals with type 2 diabetes, the HbA1c test remains a crucial and dependable tool. However, it might occasionally be more difficult to interpret HbA1c values in later stages of CKD. Fructosamine, a shorter-term blood sugar indicator, can offer useful further information in certain situations. We advise combining the 2 tests for optimal diabetes management: fructosamine for prompt medication modifications, particularly in advanced CKD and HbA1c for long term trends and risk assessments.